Anar al contingut
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avançada
  • IMMUNOLOGICAL CONSEQUENCES AND...
  • Citar
  • Enviar aquest missatge de text
  • Enviar per correu electrònic aquest
  • Imprimir
  • Exportar registre
    • Exportar a RefWorks
    • Exportar a EndNoteWeb
    • Exportar a EndNote
  • Enllaç permanent
IMMUNOLOGICAL CONSEQUENCES AND TRAFFICKING OF HUMAN REGULATORY MACROPHAGES ADMINISTERED TO RENAL TRANSPLANT RECIPIENTS

IMMUNOLOGICAL CONSEQUENCES AND TRAFFICKING OF HUMAN REGULATORY MACROPHAGES ADMINISTERED TO RENAL TRANSPLANT RECIPIENTS

Dades bibliogràfiques
Autors principals: Hutchinson, J, Riquelme, P, Sawitzki, B, Tomiuk, S, Miqueu, P, Zuhayra, M, Oberg, H, Pascher, A, Luetzen, U, Janssen, U, Broichhausen, C, Renders, L, Thaiss, F, Scheuermann, E, Henze, E, Volk, H, Chatenoud, L, Lechler, R, Wood, K, Kabelitz, D, Schlitt, H, Geissler, E, Faendrich, F
Format: Journal article
Publicat: 2011
  • Fons
  • Descripció
  • Ítems similars
  • Visualització del personal

Ítems similars

  • Cutting Edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients.
    per: Hutchinson, J, et al.
    Publicat: (2011)
  • Cutting edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients
    per: Hutchinson, J, et al.
    Publicat: (2011)
  • In question: the scientific value of preclinical safety pharmacology and toxicology studies with cell-based therapies
    per: Christiane Broichhausen, et al.
    Publicat: (2014-01-01)
  • Sequential Targeting of CD52 and TNF Allows Early Minimization Therapy in Kidney Transplantation: From a Biomarker to Targeting in a Proof-Of-Concept Trial.
    per: Ondrej Viklicky, et al.
    Publicat: (2017-01-01)
  • TIGIT+ iTregs elicited by human regulatory macrophages control T cell immunity
    per: Paloma Riquelme, et al.
    Publicat: (2018-07-01)

Opcions de cerca

  • Historial de cerca
  • Cerca avançada

Trobar-ne més

  • Explorar el catàleg
  • Explorar alfabèticament
  • Explora canals
  • Bibliografia recomanada
  • Nous ítems

Necessites ajuda?

  • Consells de cerca
  • Pregunteu al bibliotecari
  • FAQs